Announcements Trials

Browse Landscape

Status

Withdrawn 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 9 Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Neoplasms, Second Primary 1

Interventions

Surveys and Questionnaires 38 Blood Specimen Collection 24 Specimen Handling 14 Radiotherapy 12 Surgical Procedures, Operative 10 Interviews as Topic 10 Observation 9 Magnetic Resonance Spectroscopy 9 Drug Therapy 9 Data Collection 8 Immunotherapy 7 Watchful Waiting 5 Tomography, X-Ray Computed 5 Radiosurgery 5 Nivolumab 5 Mastectomy, Segmental 5 Biopsy 5 ribociclib 4 palbociclib 4 Therapeutics 4 Positron Emission Tomography Computed Tomography 4 Mental Status and Dementia Tests 4 Magnetic Resonance Imaging 4 Ipilimumab 4 Immune Checkpoint Inhibitors 4 High-Throughput Nucleotide Sequencing 4 Echocardiography 4 Bevacizumab 4 lorlatinib 3 atezolizumab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Observational × Bleomycin × Clear all

NCT03199300 2025-12-11

InvestiCAT

University Medical Center Groningen

Active not recruiting

Neoplasms, Second Primary

Data powered by HemOnc (CC BY 4.0) Colophon ⚡